Shares in Samsung BioLogics Co Ltd plunged on Monday amid concerns about its accounting practices ahead of a meeting of regulators this week to review whether it has violated rules which could lead to its delisting.
from Reuters: Money News https://ift.tt/2PQApvr
via
IFTTT
0 comments: